Abstract
Tumour-associated ligands of the activating NKG2D (natural killer group 2, member D; also called KLRK1) receptor—which are induced by genotoxic or cellular stress—trigger activation of natural killer cells and co-stimulation of effector T cells, and may thus promote resistance to cancer1,2,3,4,5,6. However, many progressing tumours in humans counter this anti-tumour activity by shedding the soluble major histocompatibility complex class-I-related ligand MICA, which induces internalization and degradation of NKG2D and stimulates population expansions of normally rare NKG2D+CD4+ T cells with negative regulatory functions7,8,9. Here we show that on the surface of tumour cells, MICA associates with endoplasmic reticulum protein 5 (ERp5; also called PDIA6 or P5), which, similar to protein disulphide isomerase, usually assists in the folding of nascent proteins inside cells10. Pharmacological inhibition of thioreductase activity and ERp5 gene silencing revealed that cell-surface ERp5 function is required for MICA shedding. ERp5 and membrane-anchored MICA form transitory mixed disulphide complexes from which soluble MICA is released after proteolytic cleavage near the cell membrane. Reduction of the seemingly inaccessible disulphide bond in the membrane-proximal α3 domain of MICA must involve a large conformational change that enables proteolytic cleavage. These results uncover a molecular mechanism whereby domain-specific deconstruction regulates MICA protein shedding, thereby promoting tumour immune evasion, and identify surface ERp5 as a strategic target for therapeutic intervention.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cerwenka, A., Baron, J. L. & Lanier, L. L. Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo. Proc. Natl Acad. Sci. USA 98, 11521–11526 (2001)
Diefenbach, A., Jensen, E. R., Jamieson, A. M. & Raulet, D. H. Rae1 and H60 ligands of the NKG2D receptor stimulate tumor immunity. Nature 413, 165–171 (2001)
Girardi, M. et al. Regulation of cutaneous malignancy by γδ T cells. Science 294, 605–609 (2001)
Gasser, S., Orsulic, S., Brown, E. J. & Raulet, D. H. The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436, 1186–1190 (2005)
Smyth, M. J. et al. NKG2D function protects the host from tumor initiation. J. Exp. Med. 202, 583–588 (2005)
Gonzalez, S., Groh, V. & Spies, T. Immunobiology of human NKG2D and its ligands. Curr. Top. Microbiol. Immunol. 298, 121–138 (2006)
Groh, V., Wu, J., Yee, C. & Spies, T. Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature 419, 734–738 (2002)
Doubrovina, E. S. et al. Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon carcinoma. J. Immunol. 171, 6891–6899 (2003)
Groh, V., Smythe, K., Dai, Z. & Spies, T. Fas ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity. Nature Immunol. 7, 755–762 (2006)
Ellgaard, L. & Ruddock, L. W. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep. 6, 28–32 (2005)
Jinushi, M., Hodi, F. S. & Dranoff, G. Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity. Proc. Natl Acad. Sci. USA 103, 9190–9195 (2006)
Oppenheim, D. E. et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nature Immunol. 6, 928–937 (2005)
Bauer, S. et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727–729 (1999)
Cosman, D. et al. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14, 123–133 (2001)
Kikuchi, M., Doi, E., Tsujimoto, I., Horibe, T. & Tsujimoto, Y. Functional analysis of human P5, a protein disulfide isomerase homologue. J. Biochem. 132, 451–455 (2002)
Turano, C., Coppari, S., Altieri, F. & Ferraro, A. P. Proteins of the PDI family: unpredicted non-ER localizations and functions. J. Cell. Physiol. 193, 154–163 (2002)
Jordan, P. A. & Gibbins, J. M. Extracellular disulfide exchange and the regulation of cellular function. Antioxid. Redox Signal. 8, 312–324 (2006)
Gallina, A. et al. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J. Biol. Chem. 277, 50579–50588 (2002)
Frand, A. R. & Kaiser, C. A. Ero1p oxidizes protein disulfide isomerase in a pathway for disulfide bond formation in the endoplasmic reticulum. Mol. Cell 4, 469–477 (1999)
Essex, D. W., Chen, K. & Swiatkowska, M. Localization of protein disulfide isomerase to the external surface of the platelet plasma membrane. Blood 86, 2168–2173 (1995)
Groh, V. et al. Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB. Proc. Natl Acad. Sci. USA 96, 6879–6884 (1999)
Li, P. et al. Crystal structure of the MHC class I homolog MIC-A, a γδ T cell ligand. Immunity 10, 577–584 (1999)
Salih, H. R., Rammensee, H.-G. & Steinle, A. Down-regulation of MICA on human tumors by proteolytic shedding. J. Immunol. 169, 4098–4102 (2002)
Groh, V. et al. Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc. Natl Acad. Sci. USA 93, 12445–12450 (1996)
Matthias, L. J. et al. Disulfide exchange in domain 2 of CD4 is required for entry of HIV-1. Nature Immunol. 3, 727–732 (2002)
Ahamed, J. et al. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc. Natl Acad. Sci. USA 103, 13932–13937 (2006)
Maekawa, A., Schmidt, B. & Fazekas de St. Groth, B. Sanejouand, Y.-H. & Hogg, P. J. Evidence for a domain-swapped CD4 dimer as the coreceptor for binding to class II MHC. J. Immunol. 176, 6873–6878 (2006)
Li, P. et al. Complex structure of the actiavting immunoreceptor NKG2D and its MHC class I-like ligand MICA. Nature Immunol. 2, 443–451 (2001)
Acknowledgements
We thank W. Carter for protein purification advice; M. Welcker for help with siRNA expression; W. Lane and P. Gafkan for mass spectrometry analyses; K. Smythe for technical assistance; and S. Riddell for comments on the manuscript. This work was supported by the Cancer Research Institute (B.K.K.), the Spanish Fondo de Investigaciones Sanitarias (S.G.), the Deutsche Forschungsgemeinschaft (H.H.M.), the Edson Fund, the Avon Foundation Breast Cancer Immunotherapy Research Initiative, and by grants from the NIH.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests.
Supplementary information
Supplementary Information
This file contains Supplementary Figure S1 with Legend. (PDF 245 kb)
Rights and permissions
About this article
Cite this article
Kaiser, B., Yim, D., Chow, IT. et al. Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands. Nature 447, 482–486 (2007). https://doi.org/10.1038/nature05768
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature05768
This article is cited by
-
CAR-NK cells for cancer immunotherapy: from bench to bedside
Biomarker Research (2022)
-
Promoting T and NK cell attack: preserving tumor MICA/B by vaccines
Cell Research (2022)
-
A vaccine targeting resistant tumours by dual T cell plus NK cell attack
Nature (2022)
-
BCL11B regulates MICA/B-mediated immune response by acting as a competitive endogenous RNA
Oncogene (2020)
-
Downregulation of HLA-ABC expression through promoter hypermethylation and downmodulation of MIC-A/B surface expression in LMP2A-positive epithelial carcinoma cell lines
Scientific Reports (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.